Report - TUMEURS CARCINOÏDES BRONCHIQUES - SPLF · 2019. 10. 23. · Octréotide Lp 30 mg/28 J n = 216 Placebo + Octréotide LP 30 mg/28 j n = 213 Traitement jusqu’à progression R A N

Please pass captcha verification before submit form